You may have seen quite a bit of media recently about attempts to encourage the Government to fund Continuous Glucose Monitors (CGMs). There has been some widespread coverage of work being done particularly by the Danii Meads Barlow Foundation and Donna Meads-Barlow, as well as Diabetes Australia and JDRF.
It is great to see such an important issue galvanising the type 1 diabetes community and gaining the attention of policy makers. JDRF has funded a great deal of work locally and globally that has led to clear evidence of how effective, and cost-effective, CGM and related closed loop technology can be. These are all important steps on the road to one of our key research goals, a fully automated artificial pancreas.
JDRF hasn’t been as active in the media in the past few days, but we have been active in Parliament House. We have met with key policy makers and influencers on the topic of CGM reimbursement. To show our support for this issue we have attended recent important functions.
JDRF, DA, the Danii Foundation and others all share the goals of a clear pathway for consideration, access and reimbursement of CGM by Government for the type 1 diabetes community. We all know that there are more and more exciting diabetes technologies coming out in the months and years ahead, and we all want to make sure that the Australian type 1 diabetes community has access to them. Particularly when that access is available to the T1D community in other countries.
Access to CGM can be life-changing and life saving, and we are very pleased to be working with other organisation to make this a reality as soon as possible.
I will keep you up to date with our progress and activities in this area. We are also going to ask you and your friends and family to help lend your voice to this cause in advocacy.
We will coordinate all our efforts so all of us are working towards the same goal – a time when exciting new diabetes technologies are both available and reimbursed in Australia for those who can benefit from them most.
Chief Executive Officer and Managing Director